Delivery Order SPE2DB22D2007-SPE2DB25FJ5HS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ivermectin 1% Cream in 45-gram units, with a ceiling value of $1,108.54. This is a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, representing a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ivermectin 1% Cream in 45-gram units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,352.22 and is scheduled for completion by July 30, 2025. The contract is not designated as a set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,340.43 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Ivermectin 1% Cream in 45-gram units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open procurement requirements. The order is set for ultimate completion by July 24, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ivermectin 1% Cream in 45-gram units, with a ceiling value of $4,226.30. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 12, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,839.36 for Ivermectin 1% Cream (45GM) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order represents a single transaction under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $6,659.75 to AmerisourceBergen Drug Corp for 45 grams of Ivermectin 1% Cream under a firm fixed price contract type. The award was made on June 24, 2025, with an ultimate completion date of June 25, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this delivery order as a child contract under its larger indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency valued at $6,599.76 for Ivermectin 1% Cream in 45-gram units. The contract, awarded on August 29, 2025, with an ultimate completion date of September 2, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, aligning with the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,225.07 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of Ivermectin 1% cream (45 gm). This delivery order was placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999 through December 2025, for delivering a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ivermectin tablets, with a contract ceiling value of $2,185.96 and a completion deadline of August 22, 2025. The award, issued on August 21, 2025, represents a firm fixed-price delivery order utilizing no set-aside provisions, indicating the contract was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,376.56 Firm Fixed Price Delivery Order is for the supply of 4566602576 Ivermectin 1% Cream, 45GM. The award has an ultimate completion date of December 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5HSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Ivermectin 1% Cream in 45-gram units, valued at $1,731.77. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is scheduled for completion by September 26, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company maintains an extensive portfolio of federal medical supply contracts with the Defense Logistics Agency, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for Ivermectin represents one of numerous pharmaceutical transactions the company executes under its DLA prime vendor agreement, supporting the Defense Health Agency and other federal healthcare systems with flexible, competitive procurement mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/25/25 |